Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

Reumatismo. 2017 Dec 21;69(4):175-183. doi: 10.4081/reumatismo.2017.1007.

Abstract

Demyelinating syndrome (DS) is a rare manifestation of systemic lupus erythematosus (SLE) (1%) with high clinical heterogeneity and potentially severe prognosis. It can represent a diagnostic and therapeutic challenge for clinicians. A recent study described 5 different patterns of demyelinating disease presentation, characterised by specific clinical, laboratory and brain and spine magnetic resonance imaging abnormalities: 1) neuromyelitis optica; 2) neuromyelitis optica spectrum disorders; 3) DS prevalently involving the brain; 4) DS prevalently involving the brainstem; 5) clinically isolated syndrome. In this review we briefly discuss typical characteristics of each DS presentation in SLE and we describe 5 illustrative clinical cases, one for each subset of DS, considering both diagnostic and therapeutic options.

Keywords: Demyelinating syndrome; Magnetic resonance.; Neuropsychiatric lupus; Systemic lupus erythematosus.

Publication types

  • Review

MeSH terms

  • Adult
  • Algorithms
  • Brain / diagnostic imaging
  • Demyelinating Autoimmune Diseases, CNS / diagnostic imaging
  • Demyelinating Autoimmune Diseases, CNS / etiology*
  • Demyelinating Autoimmune Diseases, CNS / pathology
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / classification
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neuroimaging
  • Neuromyelitis Optica / diagnostic imaging
  • Neuromyelitis Optica / etiology
  • Spinal Cord / diagnostic imaging
  • Syndrome

Substances

  • Immunosuppressive Agents